nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Sudden death—Teniposide—lymphatic system cancer	0.0391	0.0391	CcSEcCtD
Amisulpride—Amenorrhoea—Mechlorethamine—lymphatic system cancer	0.0309	0.0309	CcSEcCtD
Amisulpride—Deep vein thrombosis—Fludarabine—lymphatic system cancer	0.0289	0.0289	CcSEcCtD
Amisulpride—Sudden death—Mitoxantrone—lymphatic system cancer	0.0204	0.0204	CcSEcCtD
Amisulpride—Hypokinesia—Carmustine—lymphatic system cancer	0.0167	0.0167	CcSEcCtD
Amisulpride—Menstrual disorder—Mitoxantrone—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Amisulpride—Depression—Mechlorethamine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Amisulpride—Aggression—Bleomycin—lymphatic system cancer	0.0147	0.0147	CcSEcCtD
Amisulpride—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Amisulpride—Amenorrhoea—Mitoxantrone—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Amisulpride—Neutropenia—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Amisulpride—Pulmonary embolism—Carmustine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Amisulpride—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Amisulpride—Sweating increased—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Amisulpride—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Amisulpride—Neutropenia—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Amisulpride—Sudden death—Methotrexate—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Amisulpride—Gynaecomastia—Carmustine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Amisulpride—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Amisulpride—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00964	0.00964	CcSEcCtD
Amisulpride—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0094	0.0094	CcSEcCtD
Amisulpride—Deep vein thrombosis—Methotrexate—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Amisulpride—Agitation—Teniposide—lymphatic system cancer	0.00803	0.00803	CcSEcCtD
Amisulpride—Leukopenia—Teniposide—lymphatic system cancer	0.00782	0.00782	CcSEcCtD
Amisulpride—Malnutrition—Fludarabine—lymphatic system cancer	0.00768	0.00768	CcSEcCtD
Amisulpride—Hypertension—Teniposide—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Amisulpride—Cardiac arrest—Vincristine—lymphatic system cancer	0.00741	0.00741	CcSEcCtD
Amisulpride—Weight decreased—Bleomycin—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Amisulpride—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00713	0.00713	CcSEcCtD
Amisulpride—Agitation—Fludarabine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Amisulpride—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Amisulpride—Leukopenia—Fludarabine—lymphatic system cancer	0.00688	0.00688	CcSEcCtD
Amisulpride—Pruritus—Mechlorethamine—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Amisulpride—Hypotension—Teniposide—lymphatic system cancer	0.00667	0.00667	CcSEcCtD
Amisulpride—Convulsion—Fludarabine—lymphatic system cancer	0.00666	0.00666	CcSEcCtD
Amisulpride—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Amisulpride—Neutropenia—Carmustine—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Amisulpride—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Amisulpride—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00637	0.00637	CcSEcCtD
Amisulpride—Neutropenia—Vincristine—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Amisulpride—Depression—Carmustine—lymphatic system cancer	0.00627	0.00627	CcSEcCtD
Amisulpride—Erectile dysfunction—Vincristine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Amisulpride—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Amisulpride—Vomiting—Mechlorethamine—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Amisulpride—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Amisulpride—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Amisulpride—Weight decreased—Vincristine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Amisulpride—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Amisulpride—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Amisulpride—Depression—Vincristine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Amisulpride—Weight increased—Mitoxantrone—lymphatic system cancer	0.00597	0.00597	CcSEcCtD
Amisulpride—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Amisulpride—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Amisulpride—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Amisulpride—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Amisulpride—Nausea—Mechlorethamine—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Amisulpride—Urticaria—Teniposide—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Amisulpride—Abdominal pain—Teniposide—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Amisulpride—Dyspepsia—Fludarabine—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Amisulpride—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00546	0.00546	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Amisulpride—Fatigue—Fludarabine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Amisulpride—Constipation—Fludarabine—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Amisulpride—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Amisulpride—Hypersensitivity—Teniposide—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Amisulpride—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Amisulpride—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Amisulpride—Asthenia—Teniposide—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Amisulpride—Pruritus—Teniposide—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Amisulpride—Leukopenia—Bleomycin—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Amisulpride—Cardiac disorder—Vincristine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Amisulpride—Mental disorder—Carmustine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Amisulpride—Vaginal infection—Methotrexate—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Amisulpride—Malnutrition—Carmustine—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Amisulpride—Angiopathy—Vincristine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Amisulpride—Diarrhoea—Teniposide—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Amisulpride—Mental disorder—Vincristine—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Amisulpride—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Amisulpride—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Amisulpride—Tremor—Carmustine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Amisulpride—Vomiting—Teniposide—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Amisulpride—Agitation—Carmustine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Amisulpride—Asthenia—Fludarabine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Amisulpride—Headache—Teniposide—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Amisulpride—Pruritus—Fludarabine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Amisulpride—Leukopenia—Carmustine—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Amisulpride—Agitation—Vincristine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Amisulpride—Hypotension—Bleomycin—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Amisulpride—Diarrhoea—Fludarabine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Amisulpride—Convulsion—Carmustine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Amisulpride—Hypertension—Carmustine—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Amisulpride—Nausea—Teniposide—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Amisulpride—Leukopenia—Vincristine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Amisulpride—Anxiety—Carmustine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Amisulpride—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Amisulpride—Convulsion—Vincristine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Amisulpride—Hypertension—Vincristine—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Amisulpride—Vomiting—Fludarabine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Amisulpride—Convulsion—Mitoxantrone—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Amisulpride—Hypertension—Mitoxantrone—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Amisulpride—Headache—Fludarabine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Amisulpride—Anxiety—Mitoxantrone—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Amisulpride—Nervous system disorder—Vincristine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Amisulpride—Hypotension—Carmustine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Amisulpride—Nausea—Fludarabine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Amisulpride—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Amisulpride—Urticaria—Bleomycin—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Amisulpride—Insomnia—Carmustine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Amisulpride—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Amisulpride—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Amisulpride—Hypotension—Vincristine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Amisulpride—Somnolence—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Amisulpride—Hypotension—Mitoxantrone—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Amisulpride—Insomnia—Vincristine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Amisulpride—Constipation—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Amisulpride—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Amisulpride—Somnolence—Mitoxantrone—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Amisulpride—Fatigue—Vincristine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Amisulpride—Asthenia—Bleomycin—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Amisulpride—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Amisulpride—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Amisulpride—Constipation—Vincristine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Amisulpride—Pruritus—Bleomycin—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Amisulpride—Fatigue—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Amisulpride—Constipation—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Amisulpride—Abdominal pain—Carmustine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Amisulpride—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Amisulpride—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Amisulpride—Abdominal pain—Vincristine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Amisulpride—Urticaria—Mitoxantrone—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Amisulpride—Hypersensitivity—Carmustine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Amisulpride—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Amisulpride—Vomiting—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Amisulpride—Depression—Methotrexate—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Amisulpride—Asthenia—Carmustine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Amisulpride—Hypersensitivity—Vincristine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Amisulpride—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Amisulpride—Asthenia—Vincristine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Amisulpride—Diarrhoea—Carmustine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Amisulpride—Nausea—Bleomycin—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Amisulpride—Asthenia—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Amisulpride—Dizziness—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Amisulpride—Diarrhoea—Vincristine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Amisulpride—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Amisulpride—Vomiting—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Amisulpride—Dizziness—Vincristine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Amisulpride—Headache—Carmustine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Amisulpride—Vomiting—Vincristine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Amisulpride—Headache—Vincristine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Amisulpride—Nausea—Carmustine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Amisulpride—Vomiting—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Amisulpride—Headache—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Amisulpride—Nausea—Vincristine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Amisulpride—Nausea—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Amisulpride—Headache—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Amisulpride—Nausea—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
